Skip to content

600833.SH

Shanghai No. 1 Pharmacy Co. Ltd.

SSE · Healthcare · Medical - Pharmaceuticals · CN

CNY 10.46
−1.13%
Ask drillr

Year over year

Reported trailing growth

Revenue
+7.9%
EBITDA
EBIT
-52.1%
EPS
-42.1%
Free cash flow
+279.8%
Operating cash flow
+64.6%

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
-7.1%
EBITDA
-23.6%
EBIT
-26.8%
Net income
-26.2%
EPS
-25.9%
Free cash flow
-15.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026